Joseph A. Ladapo

Joseph A. Ladapo, MD, PhD

Hospital Medicine


Link to Dr. Ladapo's complete CV

Joseph A. Ladapo, MD, PhD, is a physician and health policy researcher whose primary research interests include assessing the cost-effectiveness of diagnostic technologies and reducing the population burden of cardiovascular disease. He is Associate Professor at the David Geffen School of Medicine and cares for hospitalized patients. Previously, he served as a faculty member in the Department of Population Health at NYU School of Medicine and as a Staff Fellow at the Food and Drug Administration.

Dr. Ladapo's research program, funded by the NHLBI, NIMHD, and the Robert Wood Johnson Foundation, focuses on (1) patient-centered approaches to improving the health of individuals evaluated for coronary artery disease, and (2) behavioral economic interventions to promote sustainable cardiovascular health, including among adults with HIV. He also leads the health economic and quality of life evaluation of multiple NIH-funded randomized trials focused on cardiovascular disease and tobacco cessation. His national honors include the Daniel Ford Award for health services and outcomes research, and he was also a regular columnist for the Harvard Focus during medical school and residency, where he discussed his experiences on the medical wards and perspectives on health policy issues.

Dr. Ladapo graduated from Wake Forest University and received his MD from Harvard Medical School and his PhD in Health Policy from Harvard Graduate School of Arts and Sciences. He completed his clinical training in internal medicine at the Beth Israel Deaconess Medical Center.

Contact Information (Academic Office):
David Geffen School of Medicine at UCLA
Department of Medicine
Division of General Internal Medicine/Health Services Research (GIM/HSR)
1100 Glendon Avenue, Suite 850
Los Angeles, CA 90024
Telephone: 310-794-2728


Medical Board Certifications

Internal Medicine, American Board of Internal Medicine, 2011


Beth Israel Deaconess Med Ctr-East Campus, 2011


Beth Israel Deaconess Med Ctr-East Campus, 2009


Harvard Medical School, MD, 2008

Hospital Affiliations

Ronald Reagan UCLA Medical Center



1. Stevens ER, Farrell D, Jumkhawala SA, Ladapo JA. Quality of Health Economic Evaluations for the ACC/AHA Stable Ischemic Heart Disease Practice Guideline: A Systematic Review. Am Heart J. 2018 Jul 11;204:17-33. doi: 10.1016/j.ahj.2018.06.013.
2. Ladapo JA. Capsule Commentary on Silvestri et al., Impact of Cost Display on Ordering Patterns for Hospital Laboratory and Imaging Services. J Gen Intern Med. 2018 Aug;33(8):1383. doi: 10.1007/s11606-018-4516-5. PMCID: PMC6082188 [Available on 2019-08-01].
3. French KM, Gonzalez SZ, Sherman SE, Link AR, Malik S, Tseng CH, Jumkhawala SA, Tejada B, White A, Ladapo JA. Financial IncEntives for Smoking TreAtment: protocol of the FIESTA trial and FIESTA Oral Microbiome Substudy. Trials. 2018 Nov 21; 19(1):646. doi: 10.1186/s13063-018-3003-y. PMCID: PMC6249787.
4. Ladapo J, Pfeifer J, Pitcavage J, Williams B, Choy-Shan, A. Quantifying Sex Differences in Cardiovascular Care among Patients Evaluated for Suspected Ischemic Heart Disease. J Womens Health (Larchmt). 2018 Dec 13. doi: 10.1089/jwh.2018.7018. PMCID: PMC6537115.
5. Ladapo JA, Spritzer CE, Nguyen XV, Pool J, Lang E. Economics of MRI Operations after Implementation of Interpersonal Skills Training. J Am Coll Radiol. 2018 Dec;15(12):1775-1783. doi: 10.1016/j.jacr.2018.01.017. PMCID: PMC6129443.
6. Gul B, Lansky A, Budoff MJ, Sharp D, Maniet B, Herman L, Kuo JZ, Huang L, Monane M, Ladapo JA. The Clinical Utility of a Precision Medicine Blood Test Incorporating Age, Sex, and Gene Expression for Evaluating Women with Stable Symptoms Suggestive of Obstructive Coronary Artery Disease: Analysis from the PRESET Registry. J Womens Health (Larchmt). 2019 Jan 17. doi: 10.1089/jwh.2018.7203. PMCID: PMC6537117.
7. Mafi JN, Godoy-Travieso P, Wei E, Anders M, Amaya R, Carrillo CA, Berry JL, Sarff L, Daskivich L, Vangala S, Ladapo J, Keeler E, Damberg CL, Sarkisian C. Evaluation of an Intervention to Reduce Low-Value Preoperative Care for Patients Undergoing Cataract Surgery at a Safety-Net Health System. JAMA Intern Med. 2019 Mar 25. doi: 10.1001/jamainternmed.2018.8358. PMCID: PMC6503569.
8. Snow SC, Fonarow GC, Ladapo JA, Washington DL, Hoggatt KJ, Ziaeian B. National Rate of Tobacco and Substance Use Disorders among Hospitalized Heart Failure Patients. Am J Med. 2019 Apr;132(4):478-488.e4. doi: 10.1016/j.amjmed.2018.11.038. PMCID: PMC6615901.
9. Jay M, Orstad SL, Wali S, Wylie-Rosett J, Tseng CH, Sweat V, Wittleder S, Shu SB, Goldstein NJ, Ladapo JA. Goal-directed Versus Outcome-Based Financial Incentives for Weight Loss among Low-Income Patients with Obesity: Rationale and Design of the Financial Incentives foR Weight Reduction (FIReWoRk) Randomised Controlled Trial. BMJ Open. 2019 Apr 8;9(4):e025278. doi: 10.1136/bmjopen-2018-025278. PMCID: PMC6500238.
10. Newman JD, Berger JS, Ladapo JA. Underuse of Medications and Lifestyle Counseling to Prevent Cardiovascular Disease in Patients with Diabetes. Diabetes Care. 2019 May;42(5):e75-e76. doi: 10.2337/dc18-1554. PMCID: PMC6489102.